Your browser is no longer supported. Please, upgrade your browser.
CLVS Clovis Oncology, Inc. daily Stock Chart
Clovis Oncology, Inc.
Index- P/E- EPS (ttm)-10.37 Insider Own10.02% Shs Outstand42.76M Perf Week20.49%
Market Cap2.37B Forward P/E- EPS next Y-4.98 Insider Trans0.00% Shs Float42.61M Perf Month52.03%
Income-398.00M PEG- EPS next Q-1.63 Inst Own95.30% Short Float18.66% Perf Quarter67.45%
Sales- P/S- EPS this Y-107.40% Inst Trans-0.03% Short Ratio3.74 Perf Half Y285.41%
Book/sh1.48 P/B37.47 EPS next Y45.00% ROA-71.60% Target Price46.89 Perf Year132.83%
Cash/sh7.46 P/C7.44 EPS next 5Y- ROE-226.40% 52W Range11.57 - 54.38 Perf YTD24.85%
Dividend- P/FCF- EPS past 5Y-41.20% ROI- 52W High1.99% Beta1.93
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin- 52W Low379.34% ATR3.30
Employees309 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)76.50 Volatility9.45% 7.47%
OptionableYes Debt/Eq4.93 EPS Q/Q35.00% Profit Margin- Rel Volume2.14 Prev Close53.49
ShortableYes LT Debt/Eq4.93 EarningsFeb 02 AMC Payout- Avg Volume2.13M Price55.46
Recom2.60 SMA2024.44% SMA5044.71% SMA200125.03% Volume4,479,900 Change3.68%
Jan-13-17Initiated Morgan Stanley Overweight
Dec-21-16Reiterated WallachBeth Hold $22 → $49
Dec-20-16Upgrade Chardan Capital Markets Sell → Neutral $15 → $36
Oct-25-16Initiated Chardan Capital Markets Sell $15
Sep-23-16Reiterated SunTrust Buy $38 → $50
Sep-21-16Upgrade Credit Suisse Neutral → Outperform
Sep-21-16Reiterated Stifel Buy $30 → $45
Aug-24-16Reiterated Mizuho Neutral $15 → $23
Aug-05-16Initiated SunTrust Buy
May-09-16Reiterated WallachBeth Hold $30 → $22
Apr-13-16Reiterated Mizuho Neutral $21 → $15
Apr-13-16Downgrade JP Morgan Overweight → Neutral
Apr-13-16Downgrade Credit Suisse Outperform → Neutral
Apr-04-16Resumed Piper Jaffray Neutral
Feb-29-16Reiterated Mizuho Neutral $23 → $21
Feb-26-16Reiterated Stifel Buy $45 → $30
Jan-25-16Reiterated Mizuho Neutral $35 → $23
Jan-21-16Initiated Credit Suisse Outperform
Nov-17-15Downgrade WallachBeth Buy → Hold $135 → $30
Nov-17-15Downgrade Goldman Buy → Neutral $123 → $23
Jan-13-17 07:11AM  Coverage initiated on Clovis Oncology by Morgan Stanley
Jan-10-17 09:30AM  The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron Pharmaceuticals
Jan-09-17 10:48AM  CLOVIS ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme +10.49%
08:00AM  Clovis Oncology to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-04-17 09:40PM  Clovis Oncology Announces Exercise in Full of Underwriters Option to Purchase Additional Shares of Common Stock Business Wire
09:43AM  Clovis Declares Pricing of Upsized Offering of Common Stock
Jan-03-17 06:45PM  Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock Business Wire
11:10AM  Tuesdays Biggest Biotech and Pharma Moves
06:45AM  Clovis Oncology Announces Proposed Offering of Common Stock Business Wire
06:35AM  17 Thoughts on Biotech Stocks to Kick Off 2017
Dec-30-16 04:22PM  Biotech Stocks: What to Watch in 2017 at Motley Fool
Dec-28-16 08:35AM  Eight Milestones Of 2016 In The War On Cancer at Forbes
Dec-27-16 02:32PM  Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
Dec-23-16 01:32PM  Growth-stock speculators need to tap the brakes here at MarketWatch
Dec-22-16 09:36AM  2016's Worst Clinical Failures at Motley Fool
07:21AM  Christmas Came Early for These Biotech Stocks at Motley Fool
Dec-21-16 03:26PM  4 stocks to watch at MarketWatch +8.65%
02:22PM  4 Stocks With Technical Momentum
Dec-20-16 04:25PM  Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med +5.04%
07:17AM  Clovis Scales 52-Week High on Early FDA Nod for Rubraca
Dec-19-16 08:41PM  Surprise! Clovis Oncology Nabs Early OK at Motley Fool +8.82%
05:09PM  Stock Market Roundup, Dec. 19: GOOGL & BBRY Self-Driving Cars, CLVS Soars
05:04PM  US FDA clears ovarian cancer drug for hard-to-treat disease
04:26PM  Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer Win
04:16PM  Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks
03:53PM  Clovis Wins Key FDA Approval on Ovarian Cancer Treatment
02:52PM  ADDING MULTIMEDIA and CONFERENCE CALL DETAILS Clovis Oncology Announces FDA Accelerated Approval of RUBRACA (rucaparib) for the Monotherapy Treatment of Advanced Ovarian Cancer in Women with Deleterious Germline or Somatic BRCA Mutations.. Business Wire
01:50PM  Here's Why Clovis Oncology (CLVS) Stock Is Soaring Today
01:48PM  Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Hasbro Bump
01:45PM  Clovis's ovarian cancer drug wins accelerated FDA approval Reuters
12:21PM  Clovis Oncology Gets FDA Approval for New Ovarian Cancer Drug at TheStreet
12:19PM  Clovis Oncology spikes 15% after cancer drug receives early FDA approval at CNBC
11:56AM  Clovis Oncology's ovarian cancer treatment gets FDA OK at MarketWatch
11:27AM  FDA grants accelerated approval to Clovis's ovarian cancer drug
11:16AM  Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
Dec-13-16 12:22PM  Short-Sellers Are Betting Big Against Clovis Oncology -- Here's Why They're Probably Right at Motley Fool
Dec-09-16 03:20PM  Are Successful Investors Right To Be So Bearish on Synergy Resources Corp (SYRG)? at Insider Monkey
Dec-07-16 04:32PM  Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win
Dec-05-16 05:54AM  Here is What Hedge Funds Think About Gener8 Maritime Inc (GNRT) at Insider Monkey
Dec-04-16 01:04PM  7 of the Most Shocking Biotech Pipeline Blowups of 2016 at Motley Fool
Dec-01-16 11:44AM  Lifshitz & Miller Law Firm Announces Investigation of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. and Kandi Techno PR Newswire
Nov-30-16 02:25PM  Newman Ferrara LLP Announces Corporate Governance Investigation of Clovis Oncology Inc. Business Wire
12:54PM  Does Clovis Oncology Inc (CLVS) Represent a Good Addition to Your Portfolio? at Insider Monkey
Nov-28-16 02:12PM  Clovis Oncology, Inc. :CLVS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -8.00%
Nov-23-16 03:44PM  Vetr Crowd Doesn't Like Outlook For Clovis Oncology +5.78%
Nov-17-16 07:51PM  Robbins Arroyo LLP: Clovis Oncology, Inc. (CLVS) Misled Shareholders According to a Recently Filed Lawsuit Business Wire
Nov-15-16 01:04PM  CLOVIS ONCOLOGY, INC. Financials
Nov-10-16 06:36AM  Here's Why These Biopharma Stocks Soared at Least 10% Today at Motley Fool
Nov-09-16 02:36PM  Westmoreland Coal Company (WLB), Corrections Corp Of America (CXW): Heres Why Traders Are Piling Into These Stocks at Insider Monkey +17.69%
Nov-07-16 07:31AM  Clovis (CLVS) Stock Up on Narrower-than-Expected Q3 Loss
Nov-05-16 10:07AM  Clovis 3Q Loss $66 Million or $1.70 a Share (CLVS) at Investopedia
Nov-04-16 12:49PM  CLOVIS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
05:42AM  Edited Transcript of CLVS earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-03-16 06:01PM  Clovis reports 3Q loss -7.37%
04:30PM  Clovis Oncology Inc Earnings Call scheduled for 4:30 pm ET today
04:15PM  CLOVIS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update Business Wire
07:07AM  Q3 2016 Clovis Oncology Inc Earnings Release - After Market Close
Oct-31-16 11:08AM  Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology PR Newswire
08:30AM  Clovis Oncology to Present at the 2016 Credit Suisse Healthcare Conference Business Wire
Oct-27-16 08:30AM  Clovis Oncology to Announce Third Quarter 2016 Financial Results and Host Webcast Conference Call on November 3 Business Wire
Oct-18-16 07:00PM  Cramer: This CEO just crushed it, a stock worth owning at CNBC
Oct-12-16 08:39AM  Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO
Oct-11-16 08:21AM  Tesaro Inc. Is Flying High Today (and Could Go Higher From Here) at Motley Fool
Oct-10-16 04:12PM  Tesaro Bolts On Ovarian Cancer Win Vs. AstraZeneca, AbbVie +10.30%
12:45PM  Why Clovis Oncology Inc. Rose 52.7% in September at Motley Fool
Oct-09-16 11:13AM  3 Cancer Drugs That Could Get an FDA OK Next Year at Motley Fool
Oct-08-16 08:38AM  How to Anticipate When a Positive Stock Trend Is About to Reverse
04:33AM  Tesaro's ovarian cancer drug benefits all patients in study
02:16AM  Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows
02:15AM  Tesaro ovarian cancer drug shows broad benefits in study
Oct-07-16 04:16PM  Clovis Nose-Dives On Potentially Inferior Cancer Drug Vs. AstraZeneca -17.78%
03:11PM  Clovis Oncology (CLVS) Stock Tumbles on Trial Update, SunTrust Bullish
01:19PM  Clovis' Drug Data Deja Vu at Bloomberg
12:13PM  Heres Why These Five Stocks Are in the Red Today: Clovis Oncology, Tyson Foods, Lloyds Banking Group, and More at Insider Monkey
10:28AM  Clovis Falls on Fears Ovarian Cancer Drug Inferior to Competition
08:45AM  Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress Business Wire
Oct-04-16 04:33PM  CLOVIS ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
07:35AM  Investor's Guide to This Week's Clovis, Tesaro Ovarian Cancer Drug Updates
Oct-03-16 08:39AM  6 Best Performing Drug Stocks of September
Sep-30-16 09:13AM  5 Top Performing Stocks of the Best ETF of Q3
Sep-28-16 07:55AM  Clovis Oncology Announces Rucaparib Data Presentations at ESMO 2016 Congress Business Wire
Sep-26-16 10:41AM  Moving Average Crossover Alert: Clovis Oncology (CLVS)
Sep-24-16 12:09PM  3 Biotechs That Could Be M&A Targets at Motley Fool
Sep-23-16 09:28AM  [video]Takeover Chatter Around Clovis May Be Overdone
Sep-21-16 03:38PM  4 health-care stocks to watch at MarketWatch
11:52AM  Here's Why Shares of Clovis Oncology Are Higher Wednesday at TheStreet
11:16AM  Why Traders Are Talking About Chevron, Adobe, Petrobras, and More at Insider Monkey
10:31AM  Clovis Oncology Charts Suggest Aggressive Buying
09:56AM  Clovis Oncology (CLVS) Stock Advances, Credit Suisse Upgrades
08:55AM  Morning Movers: Ensco Jumps on Goldman Upgrade; Clovis Soars at
Sep-16-16 03:27PM  Gilead ready to shop? +5.94%
Sep-15-16 11:47AM  Novavax And Three More Momentum Stocks Clear Resistance at Forbes +5.26%
11:10AM  Can The Uptrend Continue for Clovis Oncology (CLVS)?
Sep-14-16 09:34AM  4 stocks to watch at MarketWatch
Sep-13-16 03:17PM  Clovis Oncology, Inc. :CLVS-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
01:32PM  Why Gilead Sciences Loves PARPAnd You Should Too at
Sep-12-16 11:59AM  Is Clovis Oncology Still a Strong Buy? at Motley Fool
Sep-09-16 04:33PM  [$$] Would Gilead Pick Up Tesaro's PARP? at
03:46PM  Gilead Sciences: What is PARP? at
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast cancers. It has license agreements with Advenchen Laboratories LLC, Avila Therapeutics, Inc., and Pfizer Inc.; collaboration and license agreement with Les Laboratoires Servier; a drug discovery collaboration agreement with Array BioPharma Inc.; and collaboration with Foundation Medicine, Inc. Clovis Oncology, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.